The Worldwide Efficacy Testing Industry is Expected to Reach $511.6 Million by 2030 – ResearchAndMarkets.com

The Worldwide Efficacy Testing Industry is Expected to Reach $511.6 Million by 2030 - ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Efficacy Testing Market Share, Size, Trends, Industry Analysis Report, By Service Type, By Application, By Region, Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global Efficacy Testing market size is expected to reach USD 511.64 million by 2030 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

A collection of methods used in product research and development called efficacy testing are carried out to verify the claims made on your packaging or in your marketing and to test the product’s intended use. During the forecast period, industry growth is driven by rapid technological advancements. New techniques have been developed as a result of the focus on lowering lead time, sample consumption, assessment costs, and constraints associated with certain technologies.

The growing use of technology provides a chance for medium- and small-scale labs to expand their product lines and compete with major industry players, as these advancements offer benefits including enhanced sensitivity, accurate results, durability, multi-contaminant, and non-targeted monitoring with short turnaround time.

For instance, in August 2021, Eurofins strengthened its global position in cosmetics and personal care products testing and clinical services and grew its position in dermatology drug testing in order to diversify its clinical examination footprint in dermatology, for medicinal products, and medical devices.

Efficacy Testing Market Report Highlights

Disinfectant segment accounted for the largest share in 2021 owing to the rising consumer awareness of personal hygiene

Pharmaceutical manufacturing applications segment accounted for the largest share in 2021 due to the rising investment in pharmaceutical sector

North America accounted for the largest share in 2021, driven by the stringent drug development laws as well as rising government expenditure for life science research activities

Companies Mentioned

Abbott Analytical

Accugen Laboratories Inc.

Almac Group

ALS Limited

Bioscience Laboratories Inc.

Blutest Laboratories Limited

Charles River Laboratories International Inc.

Consumer Product Testing Company (CPTC)

Eurofins Scientific

Helvic Laboratories (A Tentamus Company)

Intertek Group PLC

Lucideon

Microchem Laboratory

MSL Solution Providers

Nelson Laboratories LLC (A Sotera Health Company)

North American Science Associates

Pacific Biolabs

SGS SA

Toxikon

Wuxi Apptec

The publisher has segmented the efficacy testing market report based on service type, application, and region:

Efficacy Testing, Service Type Outlook (Revenue – USD Million, 2018 – 2030)

Antimicrobial/ Preservative

Traditional Test Methods

Rapid Test Methods

Disinfectant Efficacy Testing

Surface Test Methods

Suspension Test Methods

Efficacy Testing, Application Outlook (Revenue – USD Million, 2018 – 2030)

Pharmaceutical Manufacturing Applications

Cosmetics and Personal Care Product Applications

Consumer Product Applications

Medical Device Applications

Efficacy Testing, Regional Outlook (Revenue – USD Million, 2018 – 2030)

North America

U.S

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

For more information about this report visit https://www.researchandmarkets.com/r/8lm57n

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.